Research Events
SMARCB1 Hope 2023 Symposium
Under the guidance of Olivier Delattre and Franck Bourdeaut from the Curie Institute in Paris, the groundbreaking SMARCB1 Hope 2023 Symposium gathered 30 internationally renowned experts in the SMARCB1 cancer field: oncology researchers, clinicians, scientists, biologists, immunologists, and geneticists from North America, the UK and Europe.
Over three days in the south of France, through presentations, work sessions, open discussions, and convivial lunches and dinners, the experts
assessed scientific progress – and failures – since the SMARCB1 gene was first discovered 25 years ago by Olivier Delattre and his team at Institut Curie in Paris
explored new approaches potentially conducive to the development of effective therapies
highlighted and discussed obstacles to the development of new therapies
discussed future research priorities that will lead to private and public funding for projects
planted seeds for future collaborations